Manuscripts
Showing 1587 manuscripts.
High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial
Citation
S Madhi, S Nachman, H S Schaaf, A Violari, T C Victor, G McSherry, C Mitchell, M F Cotton, IMPAACT P1041 Team, A C Hesseling, S Kim. High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial. International Journal of Tuberculosis and Lung Disease. 2012. 16: 192-195. PMID: 22236919Year
2012
Journal
International Journal of Tuberculosis and Lung Disease
Study
P1041
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.
Citation
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.. Clinical Infectious Diseases. 2012. 54: 285-93. PMID: 22144539Year
2012
Journal
Clinical Infectious Diseases
Study
P1032
Chronic Kidney Disease Associated with Perinatal HIV infection in Children and Adolescents.
Citation
Chronic Kidney Disease Associated with Perinatal HIV infection in Children and Adolescents.. Pediatrics. 2012. 27: 981-9. PMID: 22366874Year
2012
Journal
Pediatrics
Effect of pregnancy on emtricitabine pharmacokinetics
Citation
W Luo, E Capparelli, S Burchett, C Hu, H Li, J S Read, A Jennings, E Barr, E Smith, S S Rossi, M Mirochnick, A M Stek, B M Best. Effect of pregnancy on emtricitabine pharmacokinetics. HIV Medicine. 2012. 13: 226-35. PMID: 22129166Year
2012
Journal
HIV Medicine
Study
P1026S
Using cluster heat maps to investigate relationships between body composition and laboratory measurements in HIV-infected and HIV-uninfected children and young adults
Citation
Using cluster heat maps to investigate relationships between body composition and laboratory measurements in HIV-infected and HIV-uninfected children and young adults. AIDS. 2012. 59: 325-328. PMID: 22083069Year
2012
Journal
AIDS
Study
P1045
Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants
Citation
David Z D'Argenio, Mark F Cotton, Raziya Bobat, George D McSherry, Shabir A Madhi, Vincent J Carey, Heiner I Seifart, Cedric J Werely, Courtney V Fletcher, Jennifer J Kiser, Rui Zhu. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Therapeutic Drug Monitoring. 2012. 34: 446-451. PMID: 22695364Year
2012
Journal
Therapeutic Drug Monitoring
Study
P1041
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
Citation
Daniel G Muenz, Hans M L Spiegel, Daniel H Conway, Gwendolyn B Scott, Jeffrey T Talbot, David E Shapiro, Jennifer S Read, Katherine M Knapp, Susan B Brogly. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediaric Infectious Disease Journal. 2012. 31: 164-170. PMID: 21983213Year
2012
Journal
Pediaric Infectious Disease Journal
Study
P1025
Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe
Citation
Extended prophylaxis with Nevirapine and Cotrimoxazole among HIV Exposed-Uninfected Infants is Safe. AIDS. 2012. 26: 325-33. PMID: 22112598Year
2012
Journal
AIDS
HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth.
Citation
HIV disease severity and psychiatric symptomatology in perinatally HIV-infected youth.. Archives of Pediatrics and Adolescent Medicine. 2012. 166: 528-35. PMID: 22312169Year
2012
Journal
Archives of Pediatrics and Adolescent Medicine
Study
P1055
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings
Citation
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings. Pediatrics. 2012. 129: e1525-e1532. PMID: 22585772Year
2012
Journal
Pediatrics
Study
P1054